These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11867943)

  • 1. Hepatitis B virus and renal transplantation.
    Fabrizi F; Martin P; Ponticelli C
    Nephron; 2002 Mar; 90(3):241-51. PubMed ID: 11867943
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of hepatitis B in special patient populations.
    Wang HS; Han SH
    Clin Liver Dis; 2010 Aug; 14(3):505-20. PubMed ID: 20638028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B escape mutant reactivation in a renal transplant patient.
    Le Pendeven C; Cuzon G; Fontaine H; Zatla F; Schneider V; Amiel C; Khayat R; Nicolas JC; Soussan P
    J Clin Virol; 2007 Sep; 40(1):74-6. PubMed ID: 17652016
    [No Abstract]   [Full Text] [Related]  

  • 4. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
    Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
    Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of kidney donors with hepatitis B, hepatitis C, or brain tumor: a single-center experience.
    Tatar E; Turan MN; Firat O; Sezer TO; Sozbilen M; Solak I; Toz H; Hoscoskun C
    Transplant Proc; 2012; 44(6):1601-3. PubMed ID: 22841224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis D virus in Uzbekistan.
    Khodjaeva M; Ibadullaeva N; Khikmatullaeva A; Joldasova E; Said S; Shahnoza A; Ismoilov U; Caviglia GP; Rizzetto M; Musabaev E
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):238-240. PubMed ID: 32061325
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term impact of hepatitis B and C virus infection in kidney transplant recipient's survival.
    Correa JR; Rocha F; Peres AA; Gonçalves LF; Manfro RC
    Transplant Proc; 2003 May; 35(3):1076-7. PubMed ID: 12947864
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B-positive donors in renal transplantation: increasing the deceased donor pool.
    Pilmore HL; Gane EJ
    Transplantation; 2012 Aug; 94(3):205-10. PubMed ID: 22430067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis B, hepatitis delta, and human immunodeficiency virus infections in Omani patients with renal diseases.
    Aghanashinikar PN; al-Dhahry SH; al-Marhuby HA; Buhl MR; Daar AS; Al-Hasani MK
    Transplant Proc; 1992 Oct; 24(5):1913-4. PubMed ID: 1412910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.
    Maida I; Ríos MJ; Pérez-Saleme L; Ramos B; Soriano V; Pegram PS; Mura MS; Sánchez-Margalet V; Saldívar-Cornejo I; Wilkin A; Babudieri S; Núñez M
    AIDS Res Hum Retroviruses; 2008 May; 24(5):679-83. PubMed ID: 18462085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral hepatitis: how to manage type C and D infections.
    Najm W
    Geriatrics; 1997 May; 52(5):28-30, 33-4, 37. PubMed ID: 9152216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis delta: the virus and the disease.
    Rizzetto M
    J Hepatol; 1990; 11 Suppl 1():S145-8. PubMed ID: 2079573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitations of the polymerase chain reaction.
    Wu JC; Chen CL; Hou MC; Chen TZ; Lee SD; Lo KJ
    Hepatology; 1994 Apr; 19(4):836-40. PubMed ID: 8138254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.
    Veroux M; Corona D; Ekser B; Giaquinta A; Tallarita T; De Martino C; Gentile F; Virgilio C; Gagliano M; Fiamingo P; Veroux P
    Transplant Proc; 2011 May; 43(4):967-70. PubMed ID: 21620027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus: where are we and where are we going?
    Manns MP; Hadem J; Wedemeyer H
    Methods Mol Med; 2004; 96():415-43. PubMed ID: 14762285
    [No Abstract]   [Full Text] [Related]  

  • 16. Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers.
    Chen GD; Gu JL; Qiu J; Chen LZ
    Transpl Infect Dis; 2013 Jun; 15(3):300-5. PubMed ID: 23473005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus infection.
    Dienstag JL
    N Engl J Med; 2008 Oct; 359(14):1486-500. PubMed ID: 18832247
    [No Abstract]   [Full Text] [Related]  

  • 18. [The antiviral treatment impacts on clinical outcomes of renal transplantation recipients with hepatitis B virus infection].
    Wei ZW; Xu QH; Shu X; Jie YS; Zhang K; Xie QF; Li G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):224-6. PubMed ID: 20104785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the organ donor with prior hepatitis B infection: a safe option?
    Fabrizi F; Bunnapradist S; Martin P
    Int J Artif Organs; 2003 Jan; 26(1):6-11. PubMed ID: 12602463
    [No Abstract]   [Full Text] [Related]  

  • 20. Current Approach to Renal Transplantation Candidates and Potential Donors with Viral Hepatitis.
    Korucu B; Ulu S; Gungor O
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2023 Mar; 44(1):135-144. PubMed ID: 36987759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.